# IGC Pharma, Inc.: Form 8-K, filed Feb 7, 2013

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2013-02-07
- Accepted by EDGAR: Feb 7, 2013, 16:51 ET
- Period: 2013-02-05
- Accession: 0001185185-13-000264
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518513000264/indiaglobal8k020613.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518513000264/

## Items reported

- Item 3.01: Delisting notice
- Item 3.03: Change to security holders’ rights
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518513000264/indiaglobal8k020613.htm

Filed Feb 7, 2013.
Source: SEC EDGAR, the filing index for accession 0001185185-13-000264. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
